No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|22|3|585-587

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.22, Iss.3, 2015-03, pp. : 585-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natalizumab discontinuation and disease restart in pregnancy: a case series

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 131, Iss. 5, 2015-05 ,pp. : 336-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Palinacousis as Discontinuation Symptom after Antipsychotic Treatment in a Patient with First-Episode Schizophrenia

By  

Psychopathology, Vol. 43, Iss. 4, 2010-05 ,pp. : 248-249

Karger

Access to resources Recommend Favorite

Couples' approaches to changes in everyday life during the first year after stroke

By Ekstam Lisa   Tham Kerstin   Borell Lena  

Scandinavian Journal of Occupational Therapy, Vol. 18, Iss. 1, 2011-03 ,pp. : 49-58

Informa Healthcare

Access to resources Recommend Favorite

Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 21, Iss. 1, 2018-01 ,pp. : 170-178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Persistent Sexual Side Effects after SSRI Discontinuation

By  

Psychotherapy and Psychosomatics, Vol. 75, Iss. 3, 2006-04 ,pp. : 187-188

Karger

Access to resources Recommend Favorite